MedPath

Laboratorios Silanes, S.A. de C.V.

🇲🇽Mexico
Ownership
-
Employees
-
Market Cap
-
Website

Effect of DMMET-01 on Insulin Sensitivity in Naive Type 2 Diabetes Patients (CLAMP)

Phase 2
Completed
Conditions
Diabetes Type 2
Interventions
Drug: Placebo
First Posted Date
2009-07-16
Last Posted Date
2009-07-16
Lead Sponsor
Laboratorios Silanes S.A. de C.V.
Target Recruit Count
20
Registration Number
NCT00940797
Locations
🇲🇽

Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara, México, Guadalajara, Jalisco, Mexico

© Copyright 2025. All Rights Reserved by MedPath